Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

J&J Exploring Growth Abroad, Charting Health And Wellness Strategy

This article was originally published in The Tan Sheet

  • News

Executive Summary

In a challenging U.S. retail market, Johnson & Johnson's consumer division looks to expansion and innovation in emerging markets to help it recover after a slip in fourth-quarter sales

You may also be interested in...



Emerging Views On Emerging Markets: Cowen Group Healthcare Conference

PharmAsia News takes a closer look at presentations referencing emerging markets by Abbott, Amgen, Cardinal Health, Charles River Labs and J&J.

Emerging Views On Emerging Markets: Cowen Group Healthcare Conference

PharmAsia News takes a closer look at presentations referencing emerging markets by Abbott, Amgen, Cardinal Health, Charles River Labs and J&J.

J&J Sees Opportunities In Wellness Under Health Care Reform

Johnson & Johnson sees multiple business opportunities in the Obama administration's emphasis on wellness and prevention as part of its health care reform agenda

Table

View full table

Related Content

HBW Insight
Pink Sheet
Pink Sheet

Topics

Tags:
OTC Drugs
Latest Headlines

EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications

Industry & Regulators To Align Advice on COVID-19 Vaccine Updates

Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines

CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings

See All
UsernamePublicRestriction

Register

PS102539

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By